OLIG2 and brain neoplasm: In summary, our comprehensive in vivo analyses of ASCL1 and OLIG2 loss- and gain-of-functions in primary brain tumors provide proof of concept of the combinatorial function of these two bHLH transcription factors in determining the lineage hierarchy, heterogeneity, and plasticity of GBMs.